Sign in

CIK 0001850119

  • Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
842040295
Phone
+1 215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,212
in 5 filings

Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-22 Versant Venture Capital VI, L.P. 10% owner Conversion +614,095 614,095
2021-06-22 Versant Venture Capital VI, L.P. 10% owner Purchase +100,000 $20.00 $2.0M 714,095
2021-06-22 Versant Venture Capital VI, L.P. 10% owner Conversion · Series A Preferred Stock −25,000,000 0
2021-06-22 Versant Venture Capital VI, L.P. 10% owner Conversion · Series C Preferred Stock −1,545,125 0
2021-06-22 Casdin Eli Director Conversion +2,456,380 2,456,380
2021-06-22 Casdin Eli Director Purchase +750,000 $20.00 $15.0M 3,206,380
2021-06-22 Casdin Eli Director Conversion · Series C Preferred Stock −6,180,500 0
2021-06-17 Blackwell Kimberly Director Grant or award · Option (right to buy) +19,872 19,872
2021-06-17 JIMENEZ JOSEPH Director Grant or award · Option (right to buy) +19,872 19,872
2021-06-17 Casdin Eli Director Returned to the company · Option (right to buy) +39,744 39,744
2021-06-17 BUTITTA CYNTHIA M Director Grant or award · Option (right to buy) +19,872 19,872
2021-06-17 Carlo Rizzuto Director Grant or award · Option (right to buy) +39,744 39,744
2021-06-17 Riva Alessandro Director Grant or award · Option (right to buy) +19,872 19,872

Page 12 of 12 · 233 trades